While mortality rates from cancer have declined rapidly in the last 30 years, cancer incidence rates among women are steadily increasing 1. Breast, cervical, and ovarian are among the most common forms of cancer to affect women worldwide, and substantial unmet needs exist in their treatment. With recent diagnostic advances and the introduction of novel medicines, there is renewed interest and hope for progress in developing more effective gynecological and breast cancer treatments.
Success in bringing more effective treatments to market depends on designing studies that prioritize patient safety and experience. This involves tailoring recruitment strategies and trial environments to reflect the unique perspectives and needs of women.
In this webinar, we will discuss ways to enhance both patient recruitment and patient satisfaction, through a focus on safety monitoring, reducing trial burden, overcoming screening delays, providing proper training for sites, and using patient-reported outcomes as endpoints.
Register for this webinar today to explore innovative approaches to enhancing clinical trials for breast and gynecological cancers.
1 American Cancer Society. Cancer Facts & Figures 2025. Atlanta: American Cancer Society; 2025.
Speakers
Dr. Ashley Herrick, PhD, Vice President, Oncology Program Strategy, Premier Research
Dr. Ashley Herrick provides strategic planning, coordination, knowledge, and expertise for oncology projects. She has more than 15 years of experience in oncology clinical trial oversight and drug development. She has experience with all phases of clinical trials but has a keen interest and deep knowledge of early phase and first-in-man studies. She has led numerous global clinical trials and has experience with strategic management, study oversight, study start-up, efficient enrollment, and study close-out/CSR development.
Prior to joining Premier Research, Dr. Herrick was Director of Operational Strategy Management for a mid-sized CRO overseeing the strategic planning for studies. She also supported their Oncology Site Network and was responsible for oversight of a biomarker driven patient matching group. Prior to joining the CRO industry, she worked as a Program Manager for largest Phase I clinical trial unit in the country at MD Anderson Cancer Center, where she was responsible for oversight of more than 50 industry sponsored and investigator led Phase I clinical trials. As a cancer survivor herself, Dr. Herrick has a real awareness for incorporating the patient perspective into clinical trial design and she devoted her entire career to Oncology research.
Message Presenter
Dr. Sandy Shah, MD, Vice President, Medical Affairs, Oncology/Hematology, Premier Research
Dr. Sandy Shah is a board-certified medical oncologist with extensive expertise in clinical research and patient care. As VP of Oncology- Medical Affairs, at Premier Research, she provides strategic medical oversight to global oncology clinical trials, ensuring scientific integrity and patient safety throughout the research process.
She previously served as a Medical Monitor at a large CRO, where she played a key role in designing and overseeing clinical trials to advance safer and more effective cancer treatments. Prior to that, she was an Assistant Professor at Duke University, Assistant Chief, and Fellowship Director at the Durham Veterans Affairs, where she trained future oncologists. With over a decade of clinical experience, Dr. Shah has managed patients with both solid tumors and hematologic malignancies, including the management of breast and gynecologic malignancies.
Read more...
Dr. Shah has significant expertise in the management of global Phase I–IV clinical trials. She is committed to enhancing patient safety and improving trial accessibility, particularly for women’s cancer care.
She maintains an active medical license in North Carolina and is a dedicated advocate for advancing oncology research. Dr. Shah is an engaged member of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH). She continues to contribute to the field through poster presentations, publications, and thought leadership in clinical trial innovation.
Read Less...
Who Should Attend?
This webinar will benefit Managers and above at biotech and specialty pharma companies with job functions including, but not limited, to:
- Drug development
- Clinical operations
- Medical affairs
- Regulatory affairs
- Project management
What You Will Learn
Attendees will gain insights into:
- The landscape for women’s and gynecological oncology treatment
- Strategies to enhance patient recruitment
- Medical monitoring methods that help ensure patient safety and trial quality
- Case studies involving breast, cervical and ovarian cancer clinical trials
Xtalks Partner
Premier Research
Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management.
Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results.
As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account